LGALS3 and type 2 diabetes mellitus: In conclusion, serum Galectin-3 is elevated in T2D patients, and the elevated Galectin-3 plays a role in pathogenesis of T2D by disturbing insulin signaling pathway in insulin-targeting organs and inducing β-cell inflammation and death in pancreatic islets.